Each fact below includes its exact scope, evidence status and review dates. Missing or conflicting information stays unconfirmed.
Country (Wikidata; date unspecified)
Stated by a public source
United States
Wikidata Q113551500 property P17. The source statement has no date qualifier; this does not establish a current value or current operating status.
Deterministically projected from an identity-matched Wikidata record. Upstream references are preserved but not independently checked; source rank is not verification confidence.
Rule checked 2026-10-17 · Review due 2027-01-15 · Version 1
Inception (Wikidata)
Stated by a public source
2019
Wikidata Q113551500 property P571. Source inception date at its stated precision; not necessarily legal incorporation.
Deterministically projected from an identity-matched Wikidata record. Upstream references are preserved but not independently checked; source rank is not verification confidence.
Rule checked 2026-10-17 · Review due 2027-01-15 · Version 1
Molecular-glue discovery platform
Published by the business
Molecular-glue discovery platform: A research platform for designing glue libraries, synthesizing candidates and testing activity.
Research and drug-development capability; no approved therapy, clinical efficacy, patient availability or ability to target every protein is asserted.
Reviewed against captured first-party source passages by an assistant. This records the organization’s published description; it does not establish independent corroboration or a legal-register match.
Reviewed 2026-10-19 · Review due 2027-01-17 · Version 1
Official website (Wikidata; date unspecified)
Stated by a public source
https://neomorph.com/
Wikidata Q113551500 property P856. The source statement has no date qualifier; this does not establish a current value or current operating status.
Deterministically projected from an identity-matched Wikidata record. Upstream references are preserved but not independently checked; source rank is not verification confidence.
Rule checked 2026-10-17 · Review due 2027-01-15 · Version 1
Published overview
Published by the business
Neomorph develops molecular-glue degraders for targeted protein-degradation research and drug discovery. Its discovery platform combines ligase, degron and chemical diversity with structural insights and artificial intelligence to design and test candidate molecules.
Published description of Neomorph on the cited official website; observation dates are recorded with each source.
Reviewed against captured first-party source passages by an assistant. This records the organization’s published description; it does not establish independent corroboration or a legal-register match.
Reviewed 2026-10-19 · Review due 2027-01-17 · Version 1
Published research focus
Published by the business
Molecular-glue degraders and targeted protein degradation
Published description of Neomorph on the cited official website; observation dates are recorded with each source.
Reviewed against captured first-party source passages by an assistant. This records the organization’s published description; it does not establish independent corroboration or a legal-register match.